Cardiovascular Risk Factors, Metabolic Syndrome
Conditions
Keywords
white fish, Metabolic syndrome, Cardiovascular risk
Brief summary
The investigators performed this study to evaluate the efficacy of regular ingestion of white fish to reduce cardiovascular risk factors in patients with the metabolic syndrome, compared to a diet with no fish or seafood at all.
Detailed description
This study was designed as a randomized cross-over multicenter clinical trial with participating centers from the CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), coordinated by the Hospital Universitario Ramón y Cajal, Madrid. The investigators included adult patients with the metabolic syndrome as defined by the Third Report of the National Cholesterol Education Program, Adult Treatment Panel III. All the subjects were Caucasian from European ancestry. Patients were randomized after the screening visit to one of two sequences: 1) Sequence 1 to receive fish consumption first and then no fish. The individuals randomized to this arm continued with their previous alimentary habits, avoiding any significant nutritional imbalance, and with an ingestion of 7 serves of hake (each serve consisted of 100g of frozen Namibia hake, Pescanova S.A., Pontevedra, Spain) per week for a period of 8 weeks. Afterwards they continued for another 8 weeks with the same diet except for the avoidance of fish and any other seafood; 2) Sequence 2 for which they started with their previous alimentary habits, avoiding any significant nutritional imbalance, as well as any fish or seafood for the first 8 weeks. Afterwards they were changed to the same diet but with 7 serves of hake per week.
Interventions
OTHERDietary intervention with 7 servings oh white fish per week (each serve consisted of 100g of frozen Namibia hake, Pescanova S.A., Pontevedra, Spain)
OTHERPrevious alimentary habits, avoiding any significant nutritional imbalance, as well as any fish or seafood
Sponsors
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn).
Pescanova S.A., Pontevedra, Spain.
Hospital Universitario Ramon y Cajal
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* We included adult patients with the metabolic syndrome as defined by the Third Report of the National Cholesterol Education Program, Adult Treatment Panel III.
Exclusion criteria
* Fish allergy and positive antibodies to Anisakis spp. * Morbid obesity with BMI ≥40kg/m2. * Chronic renal failure. * Chronic psychopathy. * Neoplasia. * Refusal to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum lipids | 8 WEEKS | The primary outcome was to study the effects of hake consumption on lipid profiles, particularly on serum triglycerides. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Other individual components of the metabolic syndrome, C-reactive protein, fatty acids, insulin-resistance. | 8 weeks | The secondary outcomes were: the benefits on the other individual components of the metabolic syndrome, apart from lipids, as defined by the ATPIII (waist circumference, blood pressure levels, and glycemia); the effects on serum pro-inflammatory markers such as C-reactive protein, and also on insulin-resistance as calculated by the homeostasis model assessment; to identify specific biomarkers of white-fish consumption associated with the encountered benefits in patients with metabolic syndrome, specifically by measuring serum fatty acids. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Omega-3 fatty acids in random subgroup. | 8 weeks | To identify specific biomarkers of white-fish consumption associated with the encountered benefits in patients with metabolic syndrome, specifically by measuring serum fatty acids. |
Countries
Spain
Outcome results
None listed